E. Avsar Et Al. , "A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients," TURKISH JOURNAL OF GASTROENTEROLOGY , vol.24, no.4, pp.316-321, 2013
Avsar, E. Et Al. 2013. A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients. TURKISH JOURNAL OF GASTROENTEROLOGY , vol.24, no.4 , 316-321.
Avsar, E., TIFTIKCI, A., Poturoglu, S., Erzin, Y., Kocakaya, O., DİNÇER, D., ... Yildirim, B.(2013). A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients. TURKISH JOURNAL OF GASTROENTEROLOGY , vol.24, no.4, 316-321.
Avsar, Erol Et Al. "A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients," TURKISH JOURNAL OF GASTROENTEROLOGY , vol.24, no.4, 316-321, 2013
Avsar, Erol Et Al. "A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients." TURKISH JOURNAL OF GASTROENTEROLOGY , vol.24, no.4, pp.316-321, 2013
Avsar, E. Et Al. (2013) . "A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients." TURKISH JOURNAL OF GASTROENTEROLOGY , vol.24, no.4, pp.316-321.
@article{article, author={Erol Avsar Et Al. }, title={A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients}, journal={TURKISH JOURNAL OF GASTROENTEROLOGY}, year=2013, pages={316-321} }